Albert Fournier
Overview
Explore the profile of Albert Fournier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
702
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lenglet A, Liabeuf S, El Esper N, Brisset S, Mansour J, Lemaire-Hurtel A, et al.
Nephrol Dial Transplant
. 2017 Oct;
32(9):1597.
PMID: 29059402
No abstract available.
2.
Lenglet A, Liabeuf S, El Esper N, Brisset S, Mansour J, Lemaire-Hurtel A, et al.
Nephrol Dial Transplant
. 2016 May;
32(5):870-879.
PMID: 27190329
Background: Nicotinamide (NAM) has been proposed as an alternative treatment to phosphate binders for hyperphosphataemia in chronic kidney disease. Methods: The NICOREN multicentre, open-label and randomized study was designed to...
3.
Kajbaf F, Mentaverri R, Diouf M, Fournier A, Kamel S, Lalau J
Int J Endocrinol
. 2014 Sep;
2014:142468.
PMID: 25250050
Aim. To examine the relationship between plasma 25-hydroxyvitamin D (25(OH)D) levels and blood hemoglobin A1c (HbA1c) levels in diabetic patients at various stages of chronic kidney disease (CKD). Methods. We...
4.
Briet C, Saraval-Gross M, Kajbaf F, Fournier A, Hary L, Lalau J
Clin Kidney J
. 2014 Mar;
5(1):65-67.
PMID: 24596656
No abstract available.
5.
Lenglet A, Liabeuf S, Guffroy P, Fournier A, Brazier M, Massy Z
Drugs R D
. 2013 Sep;
13(3):165-73.
PMID: 24000048
Hyperphosphatemia in chronic kidney disease (CKD) has been associated with elevated cardiovascular morbidity and mortality. Serum phosphate control remains a cornerstone of the clinical management of patients with CKD, in...
6.
Oprisiu R, Fournier A, Achard J, Black S, Serot J, Godefroy O
JAMA Neurol
. 2013 Mar;
70(3):413-4.
PMID: 23478839
No abstract available.
7.
Page C, Biet A, Liabeuf S, Strunski V, Fournier A
Eur Arch Otorhinolaryngol
. 2011 Jun;
268(12):1749-53.
PMID: 21656167
The aim of the study was to evaluate the role of hypertension in patients hospitalized for serious spontaneous epistaxis. This 6-year retrospective study was based on 219 patients hospitalized in...
8.
Fournier A, Oprisiu-Fournier R, Serot J, Godefroy O, Achard J, Faure S, et al.
Expert Rev Neurother
. 2009 Sep;
9(9):1413-31.
PMID: 19769454
Our review of cohort studies and clinical trials evaluating antihypertensive drugs in the prevention of cognition decline and all dementia in patients with hypertension indicates that two antihypertensive drug classes...
9.
Oprisiu-Fournier R, Faure S, Mazouz H, Boutitie F, Serot J, Achard J, et al.
Expert Rev Neurother
. 2009 Sep;
9(9):1289-305.
PMID: 19769445
First, an update of the vascular systemic and tissue renin-angiotensin-aldosterone system is provided to explain how it is regulated at the systemic and tissue levels, and how many angiotensin peptides...
10.
Barreto D, Barreto F, Liabeuf S, Temmar M, Boitte F, Choukroun G, et al.
Clin J Am Soc Nephrol
. 2009 May;
4(6):1128-35.
PMID: 19443628
Background And Objectives: Cardiovascular disease is the main cause of mortality in chronic kidney disease (CKD) patients. Vitamin D might have beneficial effects on vascular health. The aim of this...